InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,598.63
(
0.39%
)
US TECH 100
19,992.20
(
0.41%
)
Dow Jones
39,404.77
(
0.29%
)
Brent Oil
85.23
(
0.63%
)
Bitcoin
57,760.99
(
-0.45%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120010
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: vinmantoo post# 4329

Wednesday, 07/25/2007 11:50:52 PM

Wednesday, July 25, 2007 11:50:52 PM

Post# of 19309
Welcome to the board, Vin.

>[To Pre_Clinical]: It is too soon to dismiss Factor VII and you have no idea how well any second generation Factor VII will pan out.<

Quite true. In fact, one of the second-generation FVIIa programs touted by Pre_Clinical — MAXY-Seven from Maxygen — is not doing so well. Roche recently pulled the plug on this program and returned all rights to MAXY (#msg-17854630, #msg-19911920). Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up